Publications by authors named "Gerd Bode"

Claim this Profile
W
Why CEOs need advanced education and training for optimizing decisions in the development of innovative medicinal products? justification and recommendation.
Peter-Jürgen Kramer, Gerd Bode, Rolf Bass

Front Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RETHINK project on minipigs in the toxicity testing of new medicines and chemicals: conclusions and recommendations.
Roy Forster, Gerd Bode, Lars Ellegaard, Jan-Willem van der Laan

J Pharmacol Toxicol Methods· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of the minipig as an animal model in regulatory toxicology.
Gerd Bode, Peter Clausing, Frederic Gervais, Jeanet Loegsted, Jörg Luft

J Pharmacol Toxicol Methods· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RETHINK project--minipigs as models for the toxicity testing of new medicines and chemicals: an impact assessment.
Roy Forster, Gerd Bode, Lars Ellegaard, Jan Willem van der Laan,

J Pharmacol Toxicol Methods· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term increase of serum troponin I and serum heart-type fatty acid-binding protein (H-FABP) in dogs following administration of formoterol.
Volker Strauss, Thomas Wöhrmann, Ilona Frank, Ulrich Hübel, Jörg Luft, Gerd Bode

Exp Toxicol Pathol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teratogenic effects of nitroimidazopyridazine on the CNS in fetal Wistar (WU) rats.
Thomas Woehrmann, Jutta Volland, Klaus Tuch, Gerd Bode, Ulrich Hübel

Arch Toxicol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenteritis precedes vasculitis in the rat mesentery after subacute administration of a phosphodiesterase type 4 inhibitor.
Lars Mecklenburg, Anke Heuser, Tobias Juengling, Manfred Kohler, Roman Foell, Gerd Bode

Toxicol Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICH topic: note for guidance on safety pharmacology studies for human pharmaceuticals.
Klaus Olejniczak, Gerd Bode

Fundam Clin Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of safety pharmacology endpoints into toxicology studies.
Jörg Luft, Gerd Bode

Fundam Clin Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICH topic: the draft ICH S7B step 2: note for guidance on safety pharmacology studies for human pharmaceuticals.
Gerd Bode, Klaus Olejniczak,

Fundam Clin Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis